Angiotensin-receptor blockers (ARBs) are a class of drugs approved for the treatment of several common conditions, such as hypertension and heart failure. Recently, regulatory agencies have started to identify possibly carcinogenic nitrosamines and azido compounds in a multitude of formulations of s …
The reduction in death nearly achieves significance and a combined end point including death would have achieved significance but was not calculated. Bias?